失代偿期肝硬化患者发生肝性脑病的危险因素分析

doi:10.3969/j.issn.1672-5069.2015.02.021

Abstract

Zhang Min. Risk factors influencing prognosis of patients with hepatic encephalopathy complicating uncompensated liver cirrhosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(2): 188-190.

[1] Salgado M,Cortes Y. Hepatic encephalopathy:diagnosis and treatment. Compend Contin Educ Vet,2013,35（6）:E1-9.
[2] 林志鹏,郭如意. 乙型肝炎后肝硬化合并HE的危险因素分析.中国基层医药,2014,21（1）：65-67.
[3] García-Martínez R,Simón-Talero M,Córdoba J. Prognostic assessment in patients with hepatic encephalopathy. Dis Markers,2011,31（3）:171-179.
[4] Perazzo JC,Tallis S,Delfante A. Hepatic encephalopathy:An approach to its multiple pathophysiological features. World J Hepatol,2012,4（3）:50-65.
[5] 石绣江,王月,希尔娜依·阿不都黑力,等. 肝硬化患者轻微肝性脑病临床相关危险因素分析. 实用肝脏病杂志,2012,15（6）:542-544.
[6] 陆再英,钟南山. 内科学. 7版,北京:人民卫生出版社,2008:431.
[7] Wakim-Fleming J. Hepatic encephalopathy:suspect it early in patients with cirrhosis. Cleve Clin J Med,2011,78（9）:597-605.
[8] 张绪清. HE的预防与治疗进展.实用肝脏病杂志,2014,（2）17：121-124.
[9] Onyekwere CA,Ogbera AO,Hameed L. Chronic liver disease and?hepatic encephalopathy:clinical profile and outcomes. Niger J Clin Pract,2011,14（2）：181-185.
[10] Hung TH,Tseng CW,et al. Effect of renal function impairment on the mortality of cirrhotic patients with hepatic encephalopathy:a population-based 3-year follow-up study. Medicine（Baltimore）,2014,93（14）:e79.
[11] Cordoba J,Ventura-Cots M,Simón-Talero M. Characteristics,risk factors,and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure （ACLF）. J Hepatol,2014,60（2）：275-281.
[12] Haliga R,Didita A,Anton C,et al. Updates in the pathogenesis and diagnosis of hepatic encephalopathy. Rev Med Chir Soc Med Nat Iasi,2014,118（3）：601-607.
[13] 敖丽. HE的相关危险因素及预后的分析.大连医科大学学报,2011,23（2）：112-113.
[14] 陈东风,孙文静. 肝性脑病发病机制的研究进展. 中华肝脏病杂志,2014,22（2）：84-85.

[1]	Chen Shuai, Yang Changqing.. Pathogenesis and risk factors of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 761-764.
[2]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[3]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[4]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[5]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[6]	Ma Yaqiong, Li Zhilan, Xia Bing.. Early administration of enteral nutrition and microecological agents in patients with hepatic encephalopathy [J]. Journal of Practical Hepatology, 2019, 22(6): 892-895.
[7]	Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675.
[8]	Wang Yueyuan, Wang Yan, Zhang Dandan. Short-term efficacy of terlipressin and octreotide combination in treatment of cirrhotic patients complicated by hepatorenal syndrome [J]. Journal of Practical Hepatology, 2019, 22(5): 684-687.
[9]	Zhang Mei, Shi Xiuying, Li Linjuan, et al. Hepatic expression of interferon inducible protein -10 in patients with hepatitis B liver cirrhosis and hepatogenic diabetes mellitus [J]. Journal of Practical Hepatology, 2019, 22(5): 688-691.
[10]	Dan Zhuyongji, Liu Zhilan, Lu Yanyan, et al. Efficacy of endoscopic sequential variceal 1igation plus sclerotherapy in treatment of patients with hepatitis B-induced liver cirrhosis complicated by esophageal gastric varices bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 692-695.
[11]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[12]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[13]	Chen Shan, Zhuang Huashuai, Xing Yixi, et al. Preventive application of meropenem in patients with liver cirrhosis complicated by upper gastrointestinal bleeding [J]. Journal of Practical Hepatology, 2019, 22(5): 704-707.
[14]	Xu Qilin, Hao Shaohuan, Ran Bo. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension [J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
[15]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.

Risk factors influencing prognosis of patients with hepatic encephalopathy complicating uncompensated liver cirrhosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments